Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and criteria for the categorisation of medicines

Legacy Merseyside
New Cheshire and Merseyside

Transition of Commissioning Policies

On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside.

Until such time as a single suite of commissioning policies can be developed and adopted, NHS Cheshire and Merseyside will continue to adopt and operate the CCG policies it has inherited at Place/borough level, which means that there will be no immediate change in commissioning policy for local people resident in those Places/boroughs from what was in place prior to 1st July 2022.

NHS Cheshire and Merseyside Commissioning Policies

 

Documents

Date Added: 11 - Apr - 2018

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of TAPENTADOL immediate release preparations (Palexia®) for pain relief.

Static

Body System:
Date Added: 23 - Jun - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing of TAPENTADOL prolonged release tablets (Palexia® SR) for severe chronic pain in adults only when initiated by chronic pain specialists or palliative care specialists

Static

Body System:
Date Added: 01 - Aug - 2019

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of DESICCATED THYROID EXTRACTS, e.g. Armour Thyroid, in the management of hypothyroidism.

Body System:
Date Added: 22 - May - 2019

The Pan Mersey Area Prescribing Committee recommends the prescribing of TICAGRELOR tablets (Brilique®), following specialist initiation, for the management of acute coronary syndromes in adults in accordance with NICE TA236 and for preventing atherothrombotic events after myocardial infarction in accordance with NICE TA420.

GP support resource

Static

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of TICAGRELOR tablets (Brilique®), following specialist initiation, to prevent thrombotic events post intracranial stenting.

Body System:
Date Added: 24 - May - 2018

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people < 18 years of age.

Body System:
Date Added: 27 - Jul - 2023

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of TIRBANIBULIN 10mg/g ointment (Klisyri®▼), following specialist initiation, for field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp.

NHS Cheshire and Merseyside APPROVED

Body System:
Date Added: 25 - Jan - 2024

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of TIRZEPATIDE injection (Mounjaro®▼), for treating type 2 diabetes in accordance with NICE TA924.

NHS Cheshire and Merseyside APPROVED

Body System:
Date Added: 11 - Apr - 2018

The Pan Mersey Area Prescribing Committee recommends the prescribing of tocilizumab infusion and subcutaneous injection  (RoActemra®) for the treatment of rheumatoid arthritis and adult-onset Still’s disease, and the infusion for juvenile idiopathic arthritis, as described.

Static

Body System:
Date Added: 24 - Mar - 2022

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of TOFACITINIB film-coated tablets (XELJANZ®▼) for ankylosing spondylitis.

Body System:
Date Added: 20 - Aug - 2020

The Pan Mersey Area Prescribing Committee recommends the prescribing of TOLVAPTAN tablets (Samsca®), by specialists only, for the treatment of hyponatraemia secondary to SIADH due to any cause.

Body System:
Date Added: 30 - Sep - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of ABROCITINIB tablets (Cibinqo®▼), TRALOKINUMAB injection (Adtralza®▼) or UPADACITINIB prolonged-release tablets (Rinvoq®▼), by specialists only, for treating moderate to severe atopic dermatitis in accordance with NICE TA814.

NHS Cheshire and Merseyside APPROVED

Body System:
Date Added: 04 - Jun - 2018

The Pan Mersey Area Prescribing Committee does not recommend the routine prescribing of ORAL COMBINATION PRODUCTS that are available as the separate constituents.

Body System:
Date Added: 26 - Sep - 2022

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of TRIFAROTENE cream (Aklief®▼) for treating acne vulgaris.

Body System:
Date Added: 28 - Feb - 2018

The Pan Mersey Area Prescribing Committee recommends that TRIPTORELIN (Decapeptyl® SR 3mg, 11.25mg and 22.5mg) INTRAMUSCULAR INJECTION is first choice gonadorelin analogue for prostate cancer following specialist urologist / oncologist initiation under applicable local arrangement.

Static

Body System: